BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 18573879)

  • 1. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis.
    Garrison SP; Jeffers JR; Yang C; Nilsson JA; Hall MA; Rehg JE; Yue W; Yu J; Zhang L; Onciu M; Sample JT; Cleveland JL; Zambetti GP
    Mol Cell Biol; 2008 Sep; 28(17):5391-402. PubMed ID: 18573879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.
    Michalak EM; Jansen ES; Happo L; Cragg MS; Tai L; Smyth GK; Strasser A; Adams JM; Scott CL
    Cell Death Differ; 2009 May; 16(5):684-96. PubMed ID: 19148184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Response to Non-genotoxic Activation of p53 by Nutlin3a Is Driven by PUMA-Mediated Apoptosis in Lymphoma Cells.
    Valente LJ; Aubrey BJ; Herold MJ; Kelly GL; Happo L; Scott CL; Newbold A; Johnstone RW; Huang DC; Vassilev LT; Strasser A
    Cell Rep; 2016 Mar; 14(8):1858-66. PubMed ID: 26904937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-β directly induces p53-up-regulated modulator of apoptosis (PUMA) during the rapid induction of apoptosis in myc-driven B-cell lymphomas.
    Spender LC; Carter MJ; O'Brien DI; Clark LJ; Yu J; Michalak EM; Happo L; Cragg MS; Inman GJ
    J Biol Chem; 2013 Feb; 288(7):5198-209. PubMed ID: 23243310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Puma-dependent and Puma-independent neuronal cell death pathways following prolonged proteasomal inhibition.
    Tuffy LP; Concannon CG; D'Orsi B; King MA; Woods I; Huber HJ; Ward MW; Prehn JH
    Mol Cell Biol; 2010 Dec; 30(23):5484-501. PubMed ID: 20921277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.
    Maclean KH; Dorsey FC; Cleveland JL; Kastan MB
    J Clin Invest; 2008 Jan; 118(1):79-88. PubMed ID: 18097482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.
    Hemann MT; Bric A; Teruya-Feldstein J; Herbst A; Nilsson JA; Cordon-Cardo C; Cleveland JL; Tansey WP; Lowe SW
    Nature; 2005 Aug; 436(7052):807-11. PubMed ID: 16094360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo.
    Erlacher M; Michalak EM; Kelly PN; Labi V; Niederegger H; Coultas L; Adams JM; Strasser A; Villunger A
    Blood; 2005 Dec; 106(13):4131-8. PubMed ID: 16118324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular localization of PUMA regulates its pro-apoptotic activity in Burkitt's lymphoma B cells.
    Ambroise G; Portier A; Roders N; Arnoult D; Vazquez A
    Oncotarget; 2015 Nov; 6(35):38181-94. PubMed ID: 26431330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of memory B-cell survival by the BH3-only protein Puma.
    Clybouw C; Fischer S; Auffredou MT; Hugues P; Alexia C; Bouillet P; Raphael M; Leca G; Strasser A; Tarlinton DM; Vazquez A
    Blood; 2011 Oct; 118(15):4120-8. PubMed ID: 21868573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of a Single Mcl-1 Allele Inhibits MYC-Driven Lymphomagenesis by Sensitizing Pro-B Cells to Apoptosis.
    Grabow S; Delbridge AR; Aubrey BJ; Vandenberg CJ; Strasser A
    Cell Rep; 2016 Mar; 14(10):2337-47. PubMed ID: 26947081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death.
    Akhtar RS; Geng Y; Klocke BJ; Latham CB; Villunger A; Michalak EM; Strasser A; Carroll SL; Roth KA
    J Neurosci; 2006 Jul; 26(27):7257-64. PubMed ID: 16822983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myc suppression of Nfkb2 accelerates lymphomagenesis.
    Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
    BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the translocation partner in protection against AID-dependent chromosomal translocations.
    Jankovic M; Robbiani DF; Dorsett Y; Eisenreich T; Xu Y; Tarakhovsky A; Nussenzweig A; Nussenzweig MC
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):187-92. PubMed ID: 19966290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1.
    Ray RM; Bhattacharya S; Johnson LR
    Apoptosis; 2011 Jan; 16(1):35-44. PubMed ID: 20812030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.
    Höglund A; Nilsson LM; Forshell LP; Maclean KH; Nilsson JA
    Blood; 2009 Apr; 113(18):4281-8. PubMed ID: 19179467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.